Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors

by PantheonAdmin | Oct 29, 2024 | Media Coverage

Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs

by PantheonAdmin | May 28, 2024 | Media Coverage

Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic

by PantheonAdmin | Feb 7, 2024 | News

— Dr. Rock to support Cartography in the translation of tumor-specific targets into therapeutics, with initial focus on its lead program for colorectal cancer (CRC) — SOUTH SAN FRANCISCO, February 7, 2024 Cartography Biosciences, an oncology company advancing a...

Cartography Biosciences and Nested Therapeutics: Diamonds in the rough

by PantheonAdmin | Oct 2, 2023 | Media Coverage

Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts

by PantheonAdmin | May 31, 2023 | News

—Newly appointed members Tara Arvedson, Ph.D., and Janine Schuurman, Ph.D., to support Cartography in the advancement of first-in-class precision cancer immunotherapies— May 31, 2023 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO–(BUSINESS...